Aminoltejari, Khatereh
Hird, Amanda E.
Klaassen, Zachary
Satkunasivam, Raj
Kulkarni, Girish S.
Luckenbaugh, Amy N.
Laviana, Aaron A.
Wallis, Christopher J. D.
Clark, Roderick
Article History
Received: 3 May 2022
Accepted: 10 October 2022
First Online: 11 February 2023
Disclosures
: Girish Kulkarni, Relevant Financial Activities outside the Submitted Work. Merck, Tersera, Janssen, Astra Zeneca, BMS, Verity, Emd serono, Knight therapeutics, Bayer, Christopher Wallis Consulting Fees: Janssen Oncology, SESEN Bio, Precision Point Specialty LLC. Honoraria: Bayer, EMD Serono, Haymarket Media, Healing and Cancer Foundation, Knight Therapeutics, Tolmar Pharmaceuticals Canada.